phenylacetic acid has been researched along with Prostatic Hyperplasia in 1 studies
phenylacetic acid : A monocarboxylic acid that is toluene in which one of the hydrogens of the methyl group has been replaced by a carboxy group.
Prostatic Hyperplasia: Increase in constituent cells in the PROSTATE, leading to enlargement of the organ (hypertrophy) and adverse impact on the lower urinary tract function. This can be caused by increased rate of cell proliferation, reduced rate of cell death, or both.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lipschutz, JH | 1 |
| Samid, D | 1 |
| Cunha, GR | 1 |
1 other study available for phenylacetic acid and Prostatic Hyperplasia
| Article | Year |
|---|---|
Phenylacetate is an inhibitor of prostatic growth and development in organ culture.
Topics: Animals; Animals, Newborn; Antimetabolites, Antineoplastic; Cell Differentiation; Immunohistochemist | 1996 |